FMP

FMP

Enter

CRL - Charles River Labora...

photo-url-https://images.financialmodelingprep.com/symbol/CRL.png

Charles River Laboratories International, Inc.

CRL

NYSE

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

171.04 USD

4.11 (2.4%)

CRL Financial Statements

Year

2024

2023

2022

2021

Total Revenue

4.05B

4.13B

3.98B

3.54B

Cost of Revenue

2.72B

2.63B

2.51B

2.21B

Gross Profit

1.33B

1.5B

1.46B

1.33B

Operating Expenses

1.1B

885.29M

811.68M

744.78M

Research and Development

0

0

0

0

Selling, General & Administrative Expenses

751M

747.86M

665.1M

619.92M

Selling & Marketing Expenses

0

0

0

0

General & Administrative Expenses

0

0

0

0

Other Expenses

353.47M

0

146.58M

124.86M

Operating Income

227.35M

617.26M

650.98M

589.86M

Total Other Income/Expenses Net

-134.23M

-35.98M

-27.99M

-109.15M

Income Before Tax

93.11M

581.28M

622.99M

480.71M

Income Tax

67.82M

100.91M

130.38M

81.87M

Net Income

22.2M

474.62M

486.23M

390.98M

Basic EPS

0.67

9.27

9.57

7.77

EPS Diluted

0.66

9.22

9.48

7.6

Basic Average Shares

51.27M

51.23M

50.81M

50.29M

Diluted Average Shares

51.63M

51.45M

51.3M

51.42M

EBITDA

581.14M

1.03B

1.04B

854.29M

Retained Earning Schedule

Year

2024

2023

2022

2021

Retained Earnings (Previous Year)

1.89B

1.43B

980.75M

625.41M

Net Income

22.2M

474.62M

486.23M

390.98M

Stock Repurchases

-119.17M

-24.16M

-38.65M

-40.71M

Dividend Paid

0

0

0

0

Retained Earnings

1.81B

1.89B

1.43B

980.75M

Other Distributions

-194.29M

430.16M

413.5M

314.63M

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

2.02B

2.03B

1.86B

1.58B

Annual Depreciation

361.74M

314.12M

303.87M

265.54M

Capital Expenditure

-232.97M

-318.53M

-324.73M

-228.77M

Net PPE

1.89B

2.04B

1.88B

1.55B

Intangible and Goodwill Schedule

Year

2024

2023

2022

2021

Acquisitions and Adjustments

-248.44M

245.14M

138.02M

902.71M

Goodwill (Previous Year)

3.1B

2.85B

2.71B

1.81B

Goodwill

2.85B

3.1B

2.85B

2.71B

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep